Argenx
ARGX
#458
Rank
HK$406.45 B
Marketcap
HK$6,568
Share price
0.06%
Change (1 day)
28.14%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of June 2025 : HK$0.33 Billion

According to Argenx 's latest financial reports the company's total debt is HK$0.33 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2024-12-31HK$0.30 B94.1%
2023-12-31HK$0.15 B60.89%
2022-12-31HK$97.08 M8.6%
2021-12-31HK$89.39 M19.42%
2020-12-31HK$74.86 M31.34%
2019-12-31HK$57 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31HK$22.94 M3.72%
2011-12-31HK$22.11 M